Comera Life Sciences to Participate in Four Upcoming Conferences
April 27 2023 - 7:00AM
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or
“Comera”), a life sciences company developing a new generation of
bio-innovative biologic medicines to improve patient access, safety
and convenience, today announced that its scientists and executives
will participate in four upcoming scientific and industry
conferences.
“We look forward to sharing more about our
proprietary formulation platform and partnering opportunities at
these upcoming conferences including the ways our SQore™ platform
integrates computational modeling, a robust library of excipients,
and formulation engineering to address challenges in subcutaneous
therapeutic development,” said Jeffrey Hackman, Chairman and Chief
Executive Officer of Comera.
Details on upcoming conference participation and
presentations:
Excipient World Conference & Expo 2023 (May 1-3,
2023) Location: National Harbor, Md. (Gaylord National
Resort & Convention Center)Presentation Date & Time: May 1,
2023 at 11:20 a.m. EDT Title: SQore ™ Platform Technology and
Excipients for Highly Concentrated mAb FormulationsSpeaker: Yuhong
Zeng, Ph.D., Director of Formulation at Comera
Pharma Partnering Summit (May 4-5,
2023)Location: San Diego, Calif. (DoubleTree by Hilton
Hotel San Diego)Details: Available for 1x1 meetings
onsiteParticipant: Janice Marie McCourt, Chief Business Officer at
Comera
PEGS Boston Conference & Expo (May 15-19,
2023)Location: Boston, Mass. (Hynes Convention Center
& Virtual)Booth Details: Exhibit Hall booth #222Participants:
Neal Muni, M.D., Chief Operating Officer at Comera; Robert P.
Mahoney, Ph.D., Chief Scientific Officer at Comera; members of the
Comera R & D team
BIO International Convention (June 5-8,
2023)Location: Boston, Mass. (Boston Convention &
Exhibition Center)Details: Available for 1x1 meetings
onsiteParticipants: Jeffrey Hackman, Chairman and Chief Executive
Officer at Comera; Neal Muni, M.D., Chief Operating Officer at
Comera; Michael Campbell, Chief Financial Officer at Comera; Janice
Marie McCourt, Chief Business Officer at Comera; Robert P. Mahoney,
Ph.D., Chief Scientific Officer at Comera
About Comera Life SciencesLeading a
compassionate new era in medicine, Comera Life Sciences is applying
a deep knowledge of formulation science and technology to transform
essential biologic medicines from intravenous (IV) to subcutaneous
(SQ) forms. The goal of this approach is to provide patients with
the freedom of self-injectable care, reduce institutional
dependency and to put patients at the center of their treatment
regimen.
To learn more about the Comera Life Sciences mission, as well as
the proprietary SQore™ platform, visit
https://comeralifesciences.com/.
Contacts
Comera Investor John Woolford ICR Westwicke
John.Woolford@westwicke.com
Comera Press Jon YuICR
WestwickeJon.Yu@westwicke.com
Comera Life Sciences (NASDAQ:CMRA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Comera Life Sciences (NASDAQ:CMRA)
Historical Stock Chart
From Dec 2023 to Dec 2024